Deinove

Latest news

09.07.2019

Issuance of notes convertible into new shares for a maximum amount of €15M. Issuance of a first €2.2 million tranche

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to...

24.06.2019

DNV3681's exceptional activity against bioterrorist threats presented at ASM Microbe 2019

Major Steven Zumbrun (USAMRIID [1] , U.S. Department of Defense) presented data on the in vitro...

More press releases

Antibiotic resistance, a global health challenge

The development of antibiotic resistance is, according to international organizations and governments, one of the major health challenges of the 21st century

More info

In the Medias

14.06.2019

Formule Verte | Deinove et Avril avancent sur leur nouvelle gamme d’ingrédients

La société de biotechnologies industrielles Deinove et Avril, l’acteur industriel et financier des filières des huiles et des protéines,...

05.06.2019

Zone Bourse | DEINOVE : LCM confirme sa recommandation d'Achat

LCM a confirmé sa recommandation d'Achat et son objectif de cours de 2,7 euros sur Deinove après la signature d'un partenariat avec Dow...

More press coverage

Disruptive innovation

Latest news

Antibiotic resistance, a global health challenge

In the Medias